Featured Research

from universities, journals, and other organizations

Repairing Stroke-Induced Brain Damage May Be Possible Through Brain Cell Transplantation

Date:
February 11, 1999
Source:
American Heart Association
Summary:
Researchers who have pioneered a technique of transplanting laboratory-grown neuronal cells into the brains of stroke patients say that the procedure has been performed in seven patients, and some of those patients report that the therapy may have helped to restore motor and speech skills that otherwise would have been lost forever.

NASHVILLE -- Researchers who have pioneered a technique of transplanting laboratory-grown neuronal cells into the brains of stroke patients say that the procedure has been performed in seven patients, and some of those patients report that the therapy may have helped to restore motor and speech skills that otherwise would have been lost forever.

Scientists at the University of Pittsburgh Medical Center have treated seven stroke survivors with the therapy, and they reported results from their research Feb. 4 at the 24th American Heart Association International Conference on Stroke and Cerebral Circulation.

"At this point, we're trying to evaluate if its feasible to put these cells into the brain and whether the process is safe," says the study's lead author, Douglas Kondziolka, M.D., professor of neurological surgery and radiation oncology, University of Pittsburgh School of Medicine. "To this date, it has been safe and there have been no problems noted. That's been encouraging and the most important thing is hopefully this will lead to a larger second study."

Of the seven patients who have been treated, all have been able to leave the hospital within 24 hours and three have noticed small improvements in motor skills, says Kondziolka. The patient who received the first transplant -- a 62-year old woman who suffered a major stroke in the fall of 1997 -- has felt well over the first seven months and has had slight improvements in speech, according to Kondziolka.

"An important part of the research is that this is setting the foundation for a possible future treatment," says Kondziolka. "It's like in baseball -- you don't walk up to bat your first time and try to hit a home run. If you can walk, and get on base, you can set the stage for something bigger later."

In the current study, researchers are examining men and women between the ages of 40-75 who have had a stroke from six months to six years prior to the treatment in order to determine whether or not they can get motor skills to return through transplantation.

Currently, the only option available to most stroke survivors is intensive rehabilitation in order to recover lost motor skills. This led scientists to try a more radical approach -- direct transplantation of neurons into the brain in the hopes that the new cells would link with other cells in the same area to help restore speech and movement. In the treatment, two to six million cells are transplanted in and around the stroke-damaged areas of the brain.

The primary goal of this trial is to determine whether the therapy is safe and can be tolerated by patients.

"If this first study is safe, we hope to move on to a second study that will address patients with more diverse problems, using more cells and putting them in different areas," says Kondziolka. "It's difficult to say whether the functional gains some patients have described are due to what we've done or something else. Theres still a lot of research to be done and a lot of data to be collected before we can start this in a larger number of people."

The brain cells used for the treatment are provided by Layton Bioscience, Inc. LBS-neurons, as the laboratory-grown cells are called, originate from human tumor tissue composed of embryonic-like cells. In the laboratory, scientists have manipulated these cells to produce fully differentiated, non-dividing neurons. The tumor tissue is a teratocarcinoma, which occurs in the reproductive organs.

The surgeons use a computed tomography (CT) scan of the patient's brain to identify three or more sites to inject the lab-grown cells. In the patients, the injection points are located in the basal ganglia region of the brain, says Kondziolka.

Co-authors are Lawrence Wechsler, M.D.; Keith Thulborn; Carolyn Meltzer, M.D.; Stephen Goldstein; Peter Jannetta; Carol Slagel; and Elaine Elder, Sc.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Repairing Stroke-Induced Brain Damage May Be Possible Through Brain Cell Transplantation." ScienceDaily. ScienceDaily, 11 February 1999. <www.sciencedaily.com/releases/1999/02/990211074205.htm>.
American Heart Association. (1999, February 11). Repairing Stroke-Induced Brain Damage May Be Possible Through Brain Cell Transplantation. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/1999/02/990211074205.htm
American Heart Association. "Repairing Stroke-Induced Brain Damage May Be Possible Through Brain Cell Transplantation." ScienceDaily. www.sciencedaily.com/releases/1999/02/990211074205.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins